A detailed history of Virginia Retirement Systems Et Al transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 33,200 shares of CPRX stock, worth $681,596. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,200
Previous 13,800 140.58%
Holding current value
$681,596
Previous $334,000 115.57%
% of portfolio
0.01%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 29, 2025

BUY
$21.4 - $26.31 $415,160 - $510,414
19,400 Added 140.58%
33,200 $720,000
Q1 2025

Jul 16, 2025

SELL
$19.53 - $25.74 $2.23 Million - $2.94 Million
-114,200 Reduced 89.22%
13,800 $334,000
Q3 2023

Jan 02, 2024

BUY
$11.69 - $15.02 $709,583 - $911,714
60,700 Added 90.19%
128,000 $1.5 Million
Q2 2023

Aug 22, 2023

BUY
$11.5 - $18.08 $261,050 - $410,415
22,700 Added 50.9%
67,300 $904,000
Q1 2023

Jul 11, 2023

BUY
$14.34 - $21.05 $179,250 - $263,125
12,500 Added 38.94%
44,600 $739,000
Q4 2022

May 17, 2023

SELL
$12.25 - $19.5 $339,325 - $540,150
-27,700 Reduced 46.32%
32,100 $597 Million
Q3 2022

May 16, 2023

SELL
$7.06 - $15.52 $768,834 - $1.69 Million
-108,900 Reduced 64.55%
59,800 $767 Million
Q1 2022

Apr 21, 2022

BUY
$5.31 - $8.31 $469,934 - $735,435
88,500 Added 110.35%
168,700 $1.4 Million
Q4 2021

Feb 03, 2022

SELL
$5.21 - $7.45 $64,604 - $92,380
-12,400 Reduced 13.39%
80,200 $543,000
Q3 2021

Oct 21, 2021

SELL
$4.85 - $6.04 $7,274 - $9,060
-1,500 Reduced 1.59%
92,600 $491,000
Q2 2021

Aug 13, 2021

BUY
$4.29 - $6.05 $113,685 - $160,325
26,500 Added 39.2%
94,100 $541,000
Q1 2021

Apr 30, 2021

SELL
$3.45 - $4.69 $10,350 - $14,070
-3,000 Reduced 4.25%
67,600 $312,000
Q4 2020

Feb 16, 2021

BUY
$2.97 - $3.83 $49,005 - $63,195
16,500 Added 30.5%
70,600 $236,000
Q3 2020

Nov 12, 2020

SELL
$2.97 - $5.08 $44,550 - $76,200
-15,000 Reduced 21.71%
54,100 $161,000
Q2 2020

Aug 12, 2020

BUY
$3.48 - $5.05 $144,072 - $209,070
41,400 Added 149.46%
69,100 $319,000
Q1 2020

May 12, 2020

SELL
$2.61 - $5.21 $1,566 - $3,126
-600 Reduced 2.12%
27,700 $107,000
Q4 2019

Jan 27, 2020

SELL
$3.67 - $5.7 $25,690 - $39,900
-7,000 Reduced 19.83%
28,300 $106,000
Q3 2019

Oct 22, 2019

BUY
$3.89 - $7.43 $137,317 - $262,279
35,300 New
35,300 $187,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.11B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.